drugset / Trial / NCT00265018

HD10 for Early Stages

NCT00265018

Phase 3 Completed 1370 enrolled University of Cologne
RandomizedFactorialOpen-labelTreatment

Summary

This study is designed to find the optimum radiation dose and number of cycles for an ABVD chemotherapy combined with an involved field irradiation. It is to be tested whether the reduction from 4 to 2 cycles of ABVD and/or the reduction of the radiation dose from 30 to 20 Gy is feasible without a loss of efficacy.

Timeline

Start
1998-05
Primary completion
2003-01
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown
Subject Dacarbazine Small molecule
Subject Doxorubicin Other / unclassified
Subject Vinblastine Small molecule

Indications